INSIGHTS ON DRUG DEVELOPMENT
-
![Assessing Particle Generation In A Single-Use Mixing System]( "Assessing Particle Generation In A Single-Use Mixing System")
Assessing Particle Generation In A Single-Use Mixing SystemExplore how particle levels remained stable during 24 hours of high-speed mixing, even under extreme temperatures, confirming a system’s suitability for final fill and other particulate-sensitive applications.
-
![GettyImages-2190227480-laboratory-scientists-computer-equipment-research]( "Automation Of 3D Intestinal Organoids Culture")
Automation Of 3D Intestinal Organoids CultureGain insight into how 3D organoids promise better disease modeling and drug screening and how challenges like assay complexity, reproducibility, and scalability hinder their widespread adoption in drug discovery.
-
![icellis 50]( "Scale Your Viral Vector Production With A Streamlined Bioreactor System")
Scale Your Viral Vector Production With A Streamlined Bioreactor SystemScale your viral vector or vaccine production with a streamlined, intermediate-scale bioreactor system that bridges development and commercial manufacturing, supporting applications from exosomes to vaccines.
-
![GettyImages-1435391920-cell-culture-development-well-plate]( "Seed Train Intensification Using High Cell Density Cryopreservation")
Seed Train Intensification Using High Cell Density CryopreservationStreamline your upstream bioprocessing with seed train intensification. Discover how high cell density cryopreservation reduces scale-up time, boosts consistency, and enhances manufacturing flexibility.
-
Strategies For The Development Of Safe And Effective Pediatric Formulations5/12/2025
Medicines for infants and children face unique formulation challenges. Learn about the key considerations, including developmental physiology, age specifics, palatability, ease of administration, and precise dosing.
-
AI-Enabled Phenotypic Analysis Of Label-Free Intestinal Organoids3/10/2025
Discover how advanced 3D models and AI-enabled imaging techniques revolutionize organoid research, which provides accurate phenotypic analysis to monitor growth and development in various organoid types.
-
Streamlining Drug Development: From Developability Assessment To High-Concentration Formulation Development6/19/2025
Explore a strategic approach to accelerating biologics formulation by gaining early insight into molecular properties and optimizing high-concentration conditions with minimal protein input.
-
Sensitive RNA Fluorescent Quantitation With An RNA Assay Kit4/4/2025
Accurate nucleic acid quantification is vital for applications like PCR and NGS. Discover an RNA Assay Kit that offers precise RNA measurement to enhance reliability and performance in downstream assays.
-
Accelerating Drug Development: Flexible And Fast DNA-To-IND Programs7/8/2024
Gain expert insights on how tailored approaches and innovative technologies enable fast and flexible development workflows, ultimately supporting rapid therapeutic breakthroughs.
DRUG DEVELOPMENT SOLUTIONS
-
![leica-microsystems-dm-2000-led-hero]( "Ergonomic System Microscopes for Complex Clinical Applications")
Leica DM2000 LED - Ergonomic System Microscopes for Complex Clinical Applications
-
![SCIEX M5 MicroLC System]( "SCIEX M5 MicroLC System")
See More with Microflow LC-MS
The M5 MicroLC system is the perfect balance of sensitivity and robustness—more sensitive than traditional analytical flow LC, and more flexible and more robust than nanoflow LC — giving you the potential to optimize your critical workflows, today and into the future.
-
![acquity-premier-beh-c18-column-186009453-angle-right]( "Increase Speed, Sensitivity, And Resolution With UPLC Column Technology")
Explore a system that has revolutionized analytical science and delivers faster throughput, sharper resolution, and reliable data to accelerate discovery and elevate your lab’s performance.
-
![GettyImages-1327977866-cell-culture-sample-laboratory]( "Powering Production Of Viral Vector-Based Therapies")
Gene therapies hold immense potential to provide long-lasting treatments for a wide range of diseases. At Cytiva, we offer GMP-compliant, end-to-end manufacturing solutions designed to support the development and commercialization of advanced medicines across multiple modalities – including AAV, adenovirus (AV), lentivirus (LV), plasmid DNA (pDNA) and exosomes. Our dependable suite of technologies and expertise ensures scalability, quality, and regulatory confidence at every stage of your journey.
-
![iStock-528290460-child-sick-fever-bed]( "Developing Palatable, Age Appropriate Drug Products")
Our expertise and capabilities enable us to meet the complex technical challenges of pediatric products and provide you with a unique integrated development solution.
